Home › Medical Devices
Medical Devices Market Research Reports & Consulting
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) - Global Forecast to 2024The cardiac resynchronization therapy market is projected to reach $5.1 billion by 2024 from $4.1 billion in 2019, at a CAGR of 4.4%. The growth of the Cardiac Resynchronization Therapy Market is majorly driven by the increasing incidence of target diseases (primarily due to the rising geriatric population). Rising investments and support, along with technological advancements, are also contributing to the growth of this market. Prominent players in the Cardiac Resynchronization Therapy Market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy). |
April 2019 | $ 4950 |
|
Elastography Imaging Market by Modality (Ultrasound, Magnetic Resonance Elastography), Application (Radiology, Cardiology, OB/GYN, Vascular, Orthopedic and Musculoskeletal), End User (Hospital, Surgery Center, Diagnostic Center) - Global Forecast to 2024The market for elastography imaging is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0 % during the forecast period. The growth of this market is mainly driven by the growing incidence of breast cancer and chronic liver diseases and a rising preference for minimally invasive procedures across the globe. However, the high cost of elastography imaging systems and an unfavorable reimbursement scenario are expected to restrain the growth of this market to a certain extent. |
April 2019 | $ 4950 |
|
Inflation Device Market by Display Type (Analog & Digital), Capacity (20ml, 30ml, 60ml), Application (Interventional Cardiology, Radiology, Peripheral Vascular, Urology), End User (Hospitals & Clinics, Ambulatory Surgery Centers) - Forecasts to 2024The global inflation devices market is projected to reach USD 600 Million by 2024 from USD 480 Million in 2019, at a CAGR of 4.7% from 2019 to 2024. The rising adoption of minimally invasive procedures, the presence of developed healthcare infrastructure in a majority of developed countries, the growing incidence of CVD, and the less-stringent approval procedures are contributing to the growth of the market. With the growth of the geriatric population, the prevalence of coronary artery disease is also expected to increase, which is a major target indication for interventional cardiology procedures that utilizes inflation devices to inflate and deflate the balloon. Aforementioned key factors are likely to fuel growth of inflation devices market over the forecast period. The major players operating in the inflation devices market are Merit Medical Systems (US), Boston Scientific Corporation (US), Cardinal Health (US), CONMED Corporation (US), Medtronic plc (Ireland), Acclarent Inc. (US), Cook Medical (US), Atrion Corporation (US), Becton, Dickinson and Company (US), Terumo Medical Corporation (Japan), B. Braun Melsungen AG (US), Olympus Corporation (Japan), Teleflex Incorporated (US), and US Endovascular (US), among others. |
April 2019 | $ 4950 |
|
Over The Counter/OTC Test Market by Product (Glucose Monitoring Test, Cholesterol Monitoring Test, Infectious Disease Testing, Fecal Occult Test, Urine Analysis Test, Drug Abuse Test), Technology (Immunoassay, Lateral Flow Assay)-Global Forecast to 2024The OTC tests market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during the forecast period. The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing.OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US). |
April 2019 | $ 4950 |
|
Microcatheters Market by Type (Delivery, Diagnosis, Aspiration, Steerable), Design (Single, Dual Lumen), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology, Urology), End-User (Hospital, Specialty Clinics) - Global Forecasts to 2024The global microcatheters market is projected to reach USD 924 Million by 2024 from USD 688 Million in 2018, at a CAGR of 5.0% from 2018 to 2024. The growth of this market is primarily driven by majorly driven by the growth in the target patient population (suffering from cardiovascular diseases, neurovascular disorders, and cancer), rising adoption of minimally invasive surgical procedures, and the increasing number of microcatheter-assisted clinical research studies. The major players operating in the microcatheters market are Boston Scientific Corporation (US), Medtronic Plc (Ireland), Terumo Corporation (Japan), ASAHI INTECC CO., LTD. (Japan), and MERIT MEDICAL SYSTEMS, INC. (US). The other prominent players operating in the overall microcatheters market include, Teleflex Incorporated (US), Johnson and Johnson (US), Stryker Corporation (US), Cook Group Incorporated (US), Cardinal Health, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), AngioDynamics, Inc. (US), Penumbra, Inc (US), and BTG PLC (UK), among others. |
April 2019 | $ 4950 |
|
Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of UTI and other kidney diseases.Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Bio-Rad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US) and URIT Medical Electronic Ltd. (China). |
March 2019 | $ 4950 |
|
North American Radiation Protection Apron Market by Type (Front Protection, Vest and Skirt, Pregnancy Lead Apron), Material (Lead Aprons, Lead-Free Apron, Light Lead Composite Apron), Country (US, Canada) - North America - Forecast to 2024The North American medical radiation protection aprons market is projected to reach USD 49 million by 2024 from USD 36 million in 2019, at a CAGR of 6.6% during the forecast period. Growth in this market is driven by the increasing safety awareness among people working in radiation-prone environments, growth in the number of trained radiologic technologists, growing number of orthopedic and spine surgeries, and the increasing prevalence of cancer. On the other hand, discomfort and pain due to the heavy weight of lead aprons is expected to hamper the growth of this market during the forecast period. Prominent players in the medical radiation protection aprons market include Infab Corporation (US), Bar·Ray Products (US), Burlington Medical LLC (US), Shielding International, Inc. (US), and AliMed, Inc. (US). |
March 2019 | $ 4950 |
|
Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024The global interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8% from 2019 to 2024. The growth of this market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer research. The major players operating in the interventional oncology market are Medtronic (Ireland), Boston Scientific (US), BTG plc (UK), Merit Medical Systems (US), and Terumo (Japan). The other prominent players operating in the overall interventional oncology market include AngioDynamics (US), Ethicon (part of J&J) (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves Medical (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), and Interface Biomaterials BV (Netherlands). |
March 2019 | $ 4950 |
|
Dental Consumables Market by Product (Implants, Prosthetics, Orthodontics, Endodontics, Infection Control, Periodontics, Whitening Products, Prophylaxis, Fluorides, Sealants, Splints), End-User (Hospital & Clinic, Laboratory) - Global Forecast to 2024The global dental consumables market is projected to reach USD 38.7 billion by 2024 from USD 27.9 billion in 2019, at a CAGR of 6.8% during the forecast period. The rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism, and the increasing disposable income in developing countries are the major factors driving the growth of this market. The prominent players operating in the dental consumables market include Straumann Holding AG (Switzerland), Danaher Corporation (US), Dentsply Sirona (US), 3M Company (US), Henry Schein, Inc. (US), Kuraray Co., Ltd. (Japan), Geistlich Pharma AG (Switzerland), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Mitsui Chemicals Inc. (Japan), Keystone Dental, Inc. (US), BEGO GmbH & Co. KG (Germany), Young Innovations Inc. (US), and Septodont Holding (France). |
March 2019 | $ 4950 |
|
Medical Equipment Cooling Market by Type (Liquid & Air-based Cooling), Compressor (Scroll, Screw, Centrifugal, Reciprocating), Configuration (Packaged, Modular, Split), Application (MRI, CT, PET, LINAC, Medical Lasers), End User (OEMS, Hospitals & Labs, Diagnostic Treatment Centers & Laboratories) - Global Forecast to 2024The medical equipment cooling market is projected to grow from an estimated USD 233 million in 2024 to USD 193 million by 2019, at a CAGR of 3.8% during the forecast period. Market growth of the medical equipment cooling market is mainly driven by the economic benefits offered by cooling systems, rising incidence of cancer and other diseases, and growing geriatric population. The global medical equipment cooling market is projected to reach USD 233 million by 2024 from USD 193 million in 2019, at a CAGR of 3.8%. |
March 2019 | $ 4950 |
|
Medical Vacuum System Market by Product (Standalone, Centralized, Portable), Technology (Dry Claw, Oil Sealed Rotary Vane, Liquid Ring), Application (Diagnostic, Wound Care, GYN), End user (Pharmaceutical, Diagnostic Labs) - Global Forecast to 2024The Medical Vacuum System Market is estimated to grow at a CAGR of 6.3% to reach USD 1.6 billion by 2024 from USD 1.1 billion in 2018. Factors such technological advancements in vacuum systems, stringent regulatory frameworks mandating the use of vacuum systems, the increasing number of target surgical procedures across major markets, and the rising number of Diagnostic Imaging procedures are driving the growth of the global medical vacuum systems market. Atlas Copco AB (Sweden), Gardner Denver Holdings (US), Busch Holding GmbH (Germany), Drägerwerk AG & Co. KGaA (Germany), Asahi Kasei ZOLL Medical Corporation (Japan), Olympus Corporation (Japan), ConvaTec (UK), INTEGRA Holdings (US), Allied Healthcare Products Inc. (US), Medela AG (Switzerland), Air Techniques (US), Laerdal Medical (Norway), Precision Medical, Inc. (US), Medicop (Slovenia), and Ohio Medical Corporation (US) are some major players in the global medical vacuum systems market. |
March 2019 | $ 4950 |
|
Closed System Transfer Devices Market by Closing Mechanism (Luer-Lock, Push-to-Turn), Type (Membrane-to-Membrane, Needleless), Technology (Diaphragm, Compartmentalize, Air Filtration), Component, End User (Hospital, Clinic) - Global Forecast to 2024The closed system transfer devices market is projected to reach USD 982 million by 2024 from USD 390 million in 2019, at a CAGR of 20.3%. Growth in this market is mainly driven by the rising prevalence of cancer, increasing number of oncology drug approvals, increasing use of closed system transfer devices to combat the harmful effects of cytotoxic or antineoplastic drugs, and improving regulatory guidelines regarding the safe handling and use of hazardous drugs. Prominent players in the closed system transfer devices market are Becton, Dickinson and Company (US), ICU Medical, Inc. (US), Equashield LLC. (US), B. Braun Melsungen AG (Germany), Corvida Medical (US), Yukon Medical (US), JMS Co., Ltd. (US), CODAN Medizinische Geräte GmbH & Co KG (Germany), Baxter International, Inc. (US), VICTUS (US), and Caragen Ltd. (Ireland). |
February 2019 | $ 4950 |
|
Near Infrared Imaging Market by Product Type (NIR Fluorescence Imaging, Reagents), Application (Cancer surgery, Plastic surgery, Gastrointestinal surgery) End Users (Hospitals & Clinics, Research laboratory, Pharmaceutical companies) - Global Forecast to 2023The near-infrared imaging market is projected to reach USD 822 million by 2023 from an estimated USD 416 million in 2018, at a CAGR of 14.6% during the forecast period. Growth in the near-infrared imaging market can primarily be attributed to the increasing number of surgical procedures globally and the advantages of NIR imaging over conventional visualization methods. The key players operating in the near-infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Olympus (Japan), Fluoptics (France), Hamamatsu Photonics K.K (Japan), Quest Medical Imaging B.V. (Netherlands), Mizuho Medical Co, Ltd. (Japan), Shimadzu Corporation (Japan), Visionsense (Israel), PerkinElmer, Inc. (US), LI-COR, Inc. (US), and SurgVision (Netherlands). |
February 2019 | $ 4950 |
|
Infection Control Market by Product (Disinfection (Disinfectant, Wipes, Sprays, Liquids, Disinfectors, UV, Wraps), AER, Sterilization (Steam, Hydrogen Peroxide, Radiation, Indicators, Services), End User (Hospitals, Life Science)) - Global Forecast to 2024The infection control market is projected to reach $27.5 billion by 2024 from $20.0 billion in 2019, at a CAGR of 6.6% during the forecast period. The disinfection products market is largely driven by the high incidence of HAIs and SSIs; the increasing number of surgical procedures worldwide, the rapidly growing pharmaceutical, life science and medical device industry; and the growing need for food sterilization. Some major players operating in this market include Getinge AB (Sweden), STERIS plc. (US), Advanced Sterilization Products (US), 3M Company (US), Belimed AG (Switzerland), Cantel Medical Corporation (US), MMM Group (Germany), Matachana Group (Spain), Sotera Health LLC (US), Ecolab, Inc. (US), Metrex Research Corporation (US), Reckitt Benckiser Group Plc. (UK), Miele Group (Germany), Melag (Germany), and Pal International (UK). |
February 2019 | $ 4950 |
|
Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - Global Forecast to 2024The pen needles market is expected to reach USD 1.8 billion by 2024 from an estimated USD 1.1 billion in 2019, at a CAGR of 10.8% during the forecast period. Growth in the pen needles market is mainly driven by factors such as the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. The growing preference for biosimilar drugs is another factor providing a wide range of growth opportunities for key players in the market. The key players in the pen needles market are Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), and Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), and Owen Mumford (UK). |
February 2019 | $ 4950 |
|
Ligation Devices Market by Product (Hand-held Instruments, Accessories), Procedure (Minimally Invasive & Open Surgery), Application (Gynaecology, GIT, Cardiothoracic, Urology), End User (Hospital, Nursing Homes) - Global Forecast to 2024The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. Some of the major players in this market include Ethicon (Johnson and Johnson) (US), Teleflex Incorporated (US), Olympus (Japan), Applied Medical (US), ConMed (US), Cooper Surgical (US), Genicon (US), Grena Think Medical (UK), B.Braun (Germany), and Medtronic (Ireland). |
February 2019 | $ 4950 |
|
Specimen Retrieval Market by Bag Size (5, 10, 15, 25 mm), Type (Detachable, Non-detachable), Application (Gynecology, Urology, Gastrointestinal Surgery), End User (Hospitals, Ambulatory Surgical Centers, Nursing Home) - Global Forecast to 2024The specimen retrieval systems market is projected to reach USD 290 million by 2024 from USD 230 million in 2019, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially laparoscopic surgeries. However, the high cost of specimen retrieval systems is a major challenge for this market, particularly in emerging countries. Some of the major players in this market include Johnson & Johnson Services, Inc. (US), Teleflex Incorporated (US), Applied Medical Resources Corporation (US), CONMED Corporation (US), Cooper Surgical, Inc. (US), Genicon (US), B. Braun Melsungen AG (Germany), Laprosurge (UK), Purple Surgical (UK), and Medtronic (Ireland). |
February 2019 | $ 4950 |
|
Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024The market for molecular quality controls is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The growth of this market is primarily driven by factors such as the growing adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support. The prominent players in the molecular quality controls market are SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US). |
February 2019 | $ 4950 |
|
Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 2024The market for immuno-oncology assays is expected to reach USD 5.9 billion by 2024 from USD 2.9 billion in 2018, at a CAGR of 12.7% during the forecast period. The growth of this market is primarily driven by factors such as the increasing adoption of targeted therapy over traditional therapy and increasing demand for mAbs. However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period. The key players operating in the immuno-oncology assays market are Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US). A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the immuno-oncology assays market. |
February 2019 | $ 4950 |
|
X-Ray Detector Market by Type (FPD, CSI, Gadox, CCD, Line scan), Panel (Small, Large), Portability (Fix, Portable), System (New, Retrofit), Application (Medical, Orthopedic, Mammogram, Dental, Cardiac, Veterinary, Security) - Global Forecast to 2024The X-ray detectors market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1%. Factors such as growing public and private investments in Digital Imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays are driving the growth of the X-ray detectors market. The introduction of wireless X-ray detectors, growing medical tourism in developing countries, and the emerging markets are expected to provide a wide range of growth opportunities for players in this market during the forecast period. However, the high cost of Digital X-Ray systems is expected to restrain the growth of this market. The X-ray detectors market is highly competitive with the presence of several small and big players. Some of the prominent players in the X-ray detectors market include Varex Imaging Corporation (US), Thales Group (France), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), Teledyne DALSA Inc. (US), Fujifilm Holdings Corporation (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (US), Vieworks Co., Ltd (South Korea), Analogic Corporation (US), Rayence (South Korea), and Hamamatsu Photonics K.K. (Japan). |
February 2019 | $ 4950 |
|
Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Pump & Patch), Diabetes Apps, Service, Data Management Software), Device Type (Hand-held & Wearables),End User (Hospitals & Self/home healthcare) - Global Forecast to 2024The global digital diabetes management market is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%. The growth of this market is mainly driven by the rising prevalence of diabetes, increasing focus on the development and adoption of digital platform for diabetes, and technological advancements. Prominent players in the digital diabetes management market are Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel). |
January 2019 | $ 4950 |
|
US Outpatient Surgical Procedures Market by Surgical Procedure Type (Gastrointestinal, Cardiovascular, Neurological, Orthopedic, Gynecologic, Integumentary, Ophthalmic), Patient Care Setting (Physician's Office, Hospital OPDs, ASCs) - US Forecast to 2023The number of outpatient surgical procedures in the US is expected to grow from ~129 million procedures in 2018 to ~144 million procedures by 2023, at a CAGR of 2.1% during the forecast period. The growing number of outpatient surgeries is expected to increase the adoption of capnography monitoring devices in outpatient surgical departments in the US. |
January 2019 | $ 4950 |
|
Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User - Global Forecast to 2023The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. The prominent players in the dental biomaterials market include Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland). |
January 2019 | $ 4950 |
|
Hemostasis Valve Market by Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed), Application (Angioplasty, Angiography), End User (Hospitals), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023The hemostasis valves market is projected to grow from USD 132 million in 2018 to USD 175 million by 2023, at a CAGR of 5.8% during the forecast period. Growth in the hemostasis valves market is mainly driven by the increasing number of interventional procedures. Merit Medical Systems (US), Abbott (US), Teleflex Incorporated (US), Boston Scientific (US), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (US), Freudenberg Medical (US), Scitech (Brazil), and Argon Medical (US). |
January 2019 | $ 4950 |
|
Veterinary Dental Equipment Market by Product (Work Station, X-Ray, Laser, Ultrasonic Scaler, Micromotor, Electrosurgical Unit, Handpieces, Forceps, Curettes, Retractors, Probe, Scalers), Animal, End User, and Region - Global Forecast to 2023The veterinary dental equipment market is projected to reach USD 490 million by 2023 from USD 329 million in 2018, at a CAGR of 8.3% during the forecast period. Growth in the global companion animal population, rising incidence of veterinary dental problems, and growth in the number of veterinary practitioners and income levels in developed economies during the forecast period are the primary drivers for the veterinary dental equipment market during the forecast period. The prominent players in the veterinary dental equipment market are iM3 (Australia), Dentalaire Products International (US), Henry Schein, Inc. (US), Midmark Corporation (US), Dispomed (Canada), MAI Animal Health (US), Integra LifeSciences Corporation (US), Acteon Group (UK), TECHNIK Veterinary Ltd (UK), Cislak manufacturing (US), Eickemeyer (Germany), and J&J Instruments Inc. (US). |
January 2019 | $ 4950 |
|
Surgical Retractor Market by Product (Hand-held, Self-retaining, Table-mounted, Wire), Design (Fixed, Angled, Elevated), Application (Abdominal, Cardiothoracic, Orthopedic, OB/GYN, Aesthetic), End User (Hospital, Maternity Center, ACCs) - Forecasts to 2023The surgical retractors market is projected to grow from an estimated USD 2.5 billion by 2023 from USD 1.8 billion in 2018, growing at a CAGR of 7.2% during the forecast period. Growth in the surgical retractors market is primarily driven by factors such as increasing number of surgical procedures; market availability of specialized and application specific retraction products; on-going expansion of geriatric population; and rising demand for plastic and reconstructive surgeries. |
December 2018 | $ 4950 |
|
Neonatal Care Equipment and Fetal (Labor & Delivery) Market - (Ultrasound, Doppler, Fetal Monitors (Intrapartum, Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy Devices, Ventilator, MRI, CPAP, Capnograph, Resuscitator)-Global Forecast to 2023The fetal and neonatal care equipment market is projected to grow from an estimated USD 6.4 billion in 2018 to USD 8.4 billion by 2023, at a CAGR of 5.7% during the forecast period. Growth in the fetal and neonatal care equipment market is mainly driven by the rise in number of preterm and low-weights birth infants, growing number of NICU admissions, and increased awareness of neonatal and fetal care across developing nations.GE Healthcare (U.K.), Philips Healthcare (Netherlands), Drägerwerk AG & Co. KGaA (Germany), Medtronic plc (Ireland), and Masimo Corporation (U.S.). |
December 2018 | $ 4950 |
|
Medical Gas and Equipment Market by Type (Oxygen, Nitrous Oxide, Carbon Dioxide, Gas Mixture, Vacuum System, Manifold, VIPR, Hose) Application (Respiratory, Anesthesia, Medical Imaging, Cryosurgery) End User (Hospital, Home Healthcare) - Forecast to 2023The global medical gases and equipment market is projected to reach USD 20.0 billion by 2023 from USD 14.0 billion in 2018, at a CAGR of 6.2 %. The growth of this market is mainly driven by rising ageing population and sub sequent increase in chronic diseases like COPD and asthma, technological advancement, growing home healthcare market, and growing smoking prevalence. |
December 2018 | $ 7150 |
|
ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplant, Vaccines, Clinical Trials, Cancer), End User (Hospital, Labs, Research Institute) - Global Forecast to 2023The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period. Growth in this market is driven by the rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers. On the other hand, the availability of alternative detection technologies is expected to limit market growth during the forecast period. Some of the major players in this market include Oxford Immunotec (UK), Cellular Technologies (US), Mabtech (Sweden), Becton, Dickinson and Company (US), Abcam (UK), Bio-Techne (US), Autoimmun Diagnostika (Germany), Biotech Investissement (France), Lophius Biosciences (Germany), and U-CyTech (Netherlands). |
December 2018 | $ 4950 |
|
Contact Lenses Market by Model (Daily Wear, Extended Wear), Design (Monovision, Spherical, Multifocal, Toric), Material (PMMA, Hybrid, Silicone Hydrogel), Application (Orthokeratology, Decorative Lenses), Distribution Channel - Global Forecast to 2023The global contact lenses market is projected to reach $9.2 billion by 2023 from $7.2 billion in 2018, at a CAGR of 4.9%. Growing prevalence of myopia, growing geriatric population, and increasing preference for contact lenses over prescription eyeglasses are the major factors driving the growth of this market. On the other hand, shortage of trained ophthalmologists and regulatory barriers in the contact lenses market are some of the factors restraining market growth. The report analyzes the global contact lenses market by product type (including model, design, material, color variation, and application), distribution channel, and region. The prominent players in the global contact lenses market are Johnson & Johnson (US), Alcon, Inc. (US), CooperVision, Inc. (US), and Bausch + Lomb (US), Carl Zeiss Meditech AG (Germany), HOYA Corporation (Japan), Essilor Group (France), SEED Co., Ltd. (Japan), Menicon Co., Ltd. (Japan), and BenQ Materials Corporation (Taiwan). |
November 2018 | $ 4950 |
|
Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%. Growth in the particle therapy market can be attributed to factors such as the various advantages offered by particle therapy over photon therapy, increasing adoption of particle therapy in clinical trials, growing global prevalence of cancer, and the increasing number of particle therapy centers worldwide. The major players operating in the particle therapy market are Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Oncotherapy plc (UK), and Danfysik A/S (Denmark). |
November 2018 | $ 4950 |
|
Surgical Snare Market by Usability (Singel Use, Reusable), Application (GI Endoscopy, Laparoscopy, Urology Endoscopy, Gynecology Endoscopy, Arthroscopy, Bronchoscopy, Mediastinoscopy, Laryngoscopy), End User (Hospital, ASC) - Global Forecast to 2023The market for surgical snare is expected to grow from from USD 992 million in 2018 to USD 1255 million by 2023, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The major driving factors in the surgical snares market are increasing number for colon polypectomy procedures, growth of the endoscopic ambulatory surgical centers, and a rising preference for minimally invasive surgeries are the key factors. The major surgical snares providers include Olympus (Japan), Boston Scientific (US), Cook Medical (US), CONMED Corporation (US), Medline Industries (US), Medtronic (Ireland), Steris (US), Merit Medical Systems (US), and Avalign Technologies (US). |
November 2018 | $ 4950 |
|
Medical Equipment Maintenance Market by Device (Imaging (MRI, CT, X-ray, Ultrasound), Endoscopy, Life Support Devices), Type (Preventive, Operation), Service Provider (OEM (Multi-Vendors), ISO, In-house Maintenance) & End User (Public, Private) - Forecast to 2023The medical equipment maintenance market is expected to reach USD 47.4 billion by 2023 from USD 28.9 billion in 2018, at a CAGR of 10.4% during the forecast period. Factors such as the rising focus on preventive medical equipment maintenance, adoption of innovative funding mechanism, growth in associated equipment markets, and the purchase of refurbished medical equipment are expected to drive the growth of the market. The medical equipment maintenance market is highly competitive, with the presence of both OEMs and ISOs. GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Toshiba Medical Systems Europe (Germany), FUJIFILM Holdings Corporation (Japan), Carestream Health, Inc. (U.S.), Agfa-Gevaert Group (Belgium), and Drägerwerk AG & Co. KGaA (Germany) are some of the leading OEMs. |
November 2018 | $ 4950 |
|
Lateral Flow Assay Market by Application (Clinical Testing (Pregnancy, Infectious Disease (Mosquito , Influenza, STI, Hepatitis, TB), Cardiac Marker, Lipid Test) Veterinary, Food Safety) Product (Reader, Kits) Technique, End User - Global Forecast to 2023The global lateral flow assay market is projected to reach USD 8.7 billion by 2023 from USD 6.0 billion in 2018, at a CAGR of 7.7%. The prominent players in the global lateral flow assay market are Abbott Laboratories (US), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton and Dickinson Company (US), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (The Netherlands), PerkinElmer, Inc. (US), Hologic, Inc. (US), Merck Millipore (US), Quidel Corporaton (US), Abcam plc. (US), DCN Diagnostics (US), Surmodics, Inc. (US), BioPorto Diagnostics A/S (Denmark), Chembio Diagnostic Systems, Inc. (US), Polysciences, Inc. (US), Innova Biosciences Ltd. (UK), Microcoat Biotechnologie GmbH (Germany), Senova GmbH (Germany), Scienion AG (Germany), and Orasure Diagnostics (US). |
November 2018 | $ 4950 |
|
Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure [ART (IVF, ICSI, Surrogate), Insemination, Laparoscopy, Tubal Ligation], Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Forecasts to 2023The market for infertility treatment market is expected to grow from USD 1.5 billion in 2018 to USD 2.2 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period. Growth in the infertility treatment market is primarily driven by factors such as the declining global fertility rate; rising number of fertility clinics worldwide; technological advancements; and increasing public-private investments, funds, and grants. The major players operating in the infertility treatment market include The Cooper Companies Inc. (US), Cook Group Incorporated (US), Vitrolife AB (Sweden), Thermo Fisher Scientific, Inc. (US) Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (US), The Baker Company, Inc. (US), and Kitazato (Japan) among others. |
November 2018 | $ 4950 |
|
Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) - Forecast to 2023The veterinary X-ray market is projected to reach USD 872 million by 2023 from USD 640 million in 2018, at a CAGR of 6.4%. Rising animal health expenditure and growing demand for pet insurance, increasing number of veterinary practitioners in developed regions, and growth in the companion animals market are the primary drivers for the veterinary X-ray market during the forecast period. The prominent players in the veterinary X-ray market are IDEXX (US), Fujifilm (Japan), Onex Corporation (Canada), Sedecal (Spain), Agfa-Gevaert (Belgium), Sound Technologies (US), Fujifilm Holdings Corporation (Japan), Canon, Inc (Japan), Examion (Germany), Konica Minolta (US), DRE Veterinary (US), and Heska Corporation (US). |
November 2018 | $ 4950 |
|
Pacemakers Market by Implantability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End User (Hospitals and Cardiac Centers, Ambulatory Surgical Center) - Global Forecast to 2023The pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0%. Growth in this market is driven by increasing prevalence of cardiovascular diseases and technological advancements in devices. Major vendors in the pacemakers market include Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China). |
November 2018 | $ 4950 |
|
Pedicle Screw System Market by Product Type (Monoaxial & Polyaxial Pedicle Screw), Surgery (Open Surgery, Minimal Invasive Surgery), Indication (Spinal Deformities, Spinal Trauma), Application (Thoracolumbar, Cervical Fusion) - Global Forecast to 2023The global pedicle screw systems market is expected to reach USD 724.23 million by 2023 from USD 538.64 million in 2018, at a CAGR of 6.1%. The major factors driving the growth of this market are the increasing incidence of spinal cord injuries, the growing preference for minimally invasive surgeries, and a rising geriatric population. Key players in the pedicle screw systems market include DePuy Synthesis (US), Globus Medical (US), Zimmer Biomet (US), B. Braun (US), Medtronic (Ireland), and Stryker (US). |
October 2018 | $ 4950 |
|
Wearable Injectors Market by Type (On-Body and Off-Body injectors (Infusion Pump Devices)), Therapy (Immuno-oncology, Diabetes, Cardiovascular diseases, Parkinson's disease, Thalassemia, Primary Immunodeficiency Disease) - Global Forecast to 2023The global wearable injectors market is projected to reach USD 9.41 billion by 2023 from USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period. The growth of this market is primarily driven by the growing prevalence of chronic diseases (such as cancer, diabetes, and CVD); favorable reimbursement scenario in major markets; and technological advancements in injector devices. The key players in the global wearable injectors market are Amgen (US), Medtronic (Ireland), Insulet Corporation (US), Tandem Diabetes Care (US), United Therapeutics Corporation (US), Valeritas (US), and SteadyMed Therapeutics (US). The other prominent players in this market are Ypsomed (Switzerland), Becton, Dickinson and Company (US), Enable Injections (US), Sensile Medicals (Switzerland), and Bespak (UK). |
October 2018 | $ 4950 |
|
Surgical Suture Market by Product (Automated Suturing Device (Disposable, Reuse), Suture Thread (Natural, Nylon, Prolene, Stainless Steel, Silk)), Application (Cardiac, Gynae, Ophthalmic, Orthopedic), End User (Hospital, Clinic) - Global Forecast to 2023The global surgical sutures market is projected to reach USD 5.02 billion by 2023 form USD 3.86 billion by 2018, at a CAGR of 5.4% from 2018 to 2023. The global market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures conducted, globally. The favorable reimbursement scenario for a number of surgical procedures and the launch of advanced sutures are further contributing to the market growth. The report segments the surgical sutures market by product, type, application, end user, and region. The surgical sutures market is marked by the presence of several established as well as emerging players, such as Ethicon, Inc. (US), Medtronic plc (Ireland), B.Braun Melsungen AG (Germany), Smith& Nephew plc (UK), Boston Scientific Corporation (US), Péters Surgical (France), DemeTECH Corporation (US), Internacional Farmacéutica (Mexico), Sutures India (India), EndoEvolution, LLC. (US), Apollo Endosurgery, Inc. (US), Surgical Specialties Corporation (US), and Mellon Medical B.V. (Netherlands). |
October 2018 | $ 4950 |
|
Hepatitis Test Solution/Diagnosis Market by Disease Type (Hepatitis B, HCV, HAV, HDV), Technology (ELISA, RDT, PCR, Transcription Mediated Amplification), End User (Hospitals, Diagnostic Laboratories, Blood Banks, Nursing Homes) - Global Forecast to 2023The global hepatitis test solution/diagnosis market is projected to reach USD 3.37 billion by 2023 from USD 2.66 billion in 2018, at a CAGR of 4.9% during the forecast period. This market is primarily driven by factors such as the high burden of hepatitis worldwide, increasing number of blood transfusions and donations, benefits offered by PoC instruments & kits, and awareness initiatives. Emerging markets such as China, India, Brazil, and Africa are expected to offer lucrative growth opportunities for the players in this market. However, the high cost of NAT tests and a lack of mandate for NAT in developing countries are expected to restrain the growth of this market during the forecast period. The key players operating in this market include Abbott Laboratories (US), Roche (Switzerland), Bio-Rad (US), Siemens (Germany), DiaSorin (Italy), QIAGEN (Netherlands), bioMérieux (France), Danaher (US), and Grifols (Spain). |
October 2018 | $ 4950 |
|
Flexible & Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) - Global Forecast to 2023The flexible & semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million by 2023 from USD 809.6 million in 2018, at a CAGR of 5.4%. The high incidence of urolithiasis across the globe is a major factor driving the growth of this market. The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the flexible & semi-rigid ureteroscopy market in the coming years. Some of the major players operating in this market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland). To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the Industrial Gearbox market. These players include Siemens AG (Germany), Bonfiglioli Italia S.P.A (Italy), Bondioli & Pavesi (Italy), Sew-Eurodrive (Germany), and Dana Brevini (Italy). |
September 2018 | $ 4950 |
|
Ultrasound Probe Disinfection Market by Product (Instrument, Service, Consumables (High-level Disinfectants, Disinfectant Wipes & Spray, Enzymatic Detergent)), Probe Type (Linear & Endocavity Transducer), End User (Hospitals)-Global Forecast to 2023The global ultrasound probe disinfection market is projected to reach USD 819.1 million by 2023 from USD 314.1 million in 2018, at a CAGR of 21.1%. The growth of this market is driven by factors such as the increasing number of ultrasound imaging procedures, rising incidence of hospital-acquired infections due to the improper reprocessing of ultrasound probes, increasing adoption of high-level disinfection systems for critical and semi-critical ultrasound probes, and technological advancements in ultrasound probes. |
September 2018 | $ 4950 |
|
Capnography Equipment Market by Product (Capnometer (Multiparameter, Standalone, Handheld, Conventional), Accessories), Technology (Mainstream, Sidestream), Application (Cardiac Care, Trauma, Emergency Care), End User (Hospital) - Global Forecast to 2023The global capnography equipment market is projected to reach USD 366.5 million by 2023 from USD 297.1 million in 2018, at a CAGR of 4.3%. Factors such as the development of portable/point-of-care capnography devices, clinical benefits of capnography equipment over pulse oximetry, increasing number of surgeries, and the evolving guidelines related to the clinical use of capnography are expected to drive the demand for capnography equipment during the study period. As of 2017, the various product segments considered in the capnography equipment market are dominated by NIHON KOHDEN (Japan), Medtronic (Ireland), Smiths Group (UK), and Masimo Corporation (US). These companies accounted for a major share of the global capnography equipment market in 2017. |
September 2018 | $ 4950 |
|
Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to 2023The global rapid microbiology testing market is expected to USD 5.09 billion by 2023 from USD 3.45 billion in 2018, growing at a CAGR of 8.1%. Growth in the rapid microbiology testing market can be attributed to factors such as the rising prevalence of infectious diseases; ongoing technological advancements; increasing food safety concerns; increased funding, research grants, and public-private investments; and increasing awareness about rapid microbiology testing. The major players operating in the rapid microbiology testing market include bioMérieux SA (France), Danaher Corporation (US), and Becton, Dickinson and Company (US), among others. |
September 2018 | $ 4950 |
|
Patient Temperature Monitoring Market by Product (Wearable, Non-invasive, Continuous Core, Digital, Invasive Monitors), Site (Skin, Tympanic, Rectal), Application (Fever, Hypothermia, Anesthesia), End User (Hospitals, Blood Banks) - Global Forecast to 2023The patient temperature monitoring market is projected to reach USD 3.21 billion by 2023 from USD 2.55 billion in 2018, at a CAGR of 4.7% during the forecast period. Factors such as rising prevalence of infectious diseases, increasing geriatric and pediatric population, increasing number of surgical procedures, growing number of blood transfusion procedures, rising awareness about continuous temperature monitoring, and increasing demand for advanced temperature monitoring devices are driving the growth of the market. The major players operating the global patient temperature monitoring market are 3M (US), Cardinal Health (US) Koninklijke Philips (Netherlands), Hill-Rom Holdings (US), Drägerwerk (Germany), Terumo Corporation (Japan), Masimo Corporation (US), Microlife (Taiwan), Braun GmbH, and American Diagnostic Corporation (US). |
September 2018 | $ 4950 |
|
Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023The global hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market during the forecast period. The major players in the hemostats market include CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany). |
September 2018 | $ 4950 |
|
Structural Heart Devices Market by Product (Heart Valve Devices (Transcatheter and Surgical), Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), Procedure (Replacement and Repair) - Global Forecast to 2023The global structural heart devices market is projected to reach USD 15.08 billion by 2023 from USD 9.28 billion in 2018, at a CAGR of 10.2% during the forecast period. The rising prevalence of structural heart diseases, regulatory approvals for new and advanced structural heart devices, favorable reimbursement scenario for structural heart procedures & devices, and increasing awareness about structural heart diseases are the major factors driving the growth of the structural heart devices market. However, low affordability and inaccessibility of cardiac surgeries in developing countries are expected to restrain the growth of this market in the coming years. In addition, a dearth of skilled personnel may affect overall procedural volumes and serve to slow the pace of market growth during the forecast period. Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), and LivaNova plc (UK) are the key players in the structural heart devices market. The other players in this market are CryoLife, Inc. (US), Micro Interventional Devices, Inc. (US), Braile Biomédica (Brazil), Lepu Medical Technology (Beijing) Co., Ltd. (China), and TTK Healthcare Limited (India). |
September 2018 | $ 4950 |
|
Digital X-ray Market by Application (Radiography, Orthopedic, Cardiovascular, Fluoroscopy, Chest), Technology (Direct, Computed Radiography), Portability (Handheld, Mobile), System (Retrofit, New), End User (Diagnostic Center, Hospital), Price - Global Forecast to 2023The digital X-ray market is expected to reach USD 13.04 billion by 2023 from USD 8.68 billion in 2018, at a CAGR of 8.5%. Factors such as increasing geriatric population and the subsequent growth in global disease incidence, favorable regulations and government initiatives & investments, the advantages of digital X-ray systems, and technological advancements and product development are driving the digital X-ray market. The digital X-ray market is highly competitive with the presence of several small and big players. Some of the players in the digital X-ray market are Canon Inc. (Japan), Carestream Health (US), Fujifilm Corporation (Japan), GE Healthcare (US), Hitachi Ltd. (Japan), Hologic, Inc. (US), Philips Healthcare (Netherlands), Shimadzu Corporation (Japan), Siemens Healthineers (Germany), Konica Minolta, Inc. (Japan), Samsung Medison Co., Ltd. (Korea), and Agfa Gevaert (Belgium). |
September 2018 | $ 4950 |
|
Energy Efficient Glass Market by Coating (Hard Coat, Soft Coat), Glazing (Single Glazing, Double Glazing, Triple Glazing), Application (Building & Construction, Automotive, Solar Panel), and Region- Global Forecast to 2023The global energy efficient glass market is estimated to be USD 25.11 billion in 2018 and is projected to reach USD 32.02 billion by 2023, at a CAGR of 5.0% between 2018 and 2023. The increased demand for energy efficient glass in the building & construction, automotive, and solar panel industries is expected to drive the energy efficient glass market.Companies such as Saint-Gobain S.A. (France), Nippon Sheet Glass Co., Ltd. (Japan), AGC Inc. (Japan), SCHOTT AG (Germany), Guardian Glass, LLC. (US), Sisecam Group (Turkey), and Vitro Architectural Glass (US) are the leading players in the energy efficient glass market |
September 2018 | $ 4950 |
|
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement
Connect With Us
Search reports
Medical Devices ›
Information and Communications Technology ›
Semiconductor and Electronics ›
Chemicals ›
Advanced Materials ›
Energy and Power ›
Food and Beverage ›
Biotechnology ›
Aerospace and Defence ›
Healthcare IT ›
Automotive and Transportation ›
Automation and Process Control ›
Agriculture Industry ›
Packaging ›
Pharmaceuticals ›
Building and Construction ›
Mining, Minerals and Metals ›
Analytical and Scientific Instrumentation ›
Engineering Equipment and Devices ›
'Connect With Us
